US3133068A - 5-substituted dibenz[b, f] azepine compounds - Google Patents
5-substituted dibenz[b, f] azepine compounds Download PDFInfo
- Publication number
- US3133068A US3133068A US832498A US83249859A US3133068A US 3133068 A US3133068 A US 3133068A US 832498 A US832498 A US 832498A US 83249859 A US83249859 A US 83249859A US 3133068 A US3133068 A US 3133068A
- Authority
- US
- United States
- Prior art keywords
- iminostilbene
- piperazino
- acid
- general formula
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 5-substituted dibenz[b, f] azepine compounds Chemical class 0.000 title description 25
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- 125000002947 alkylene group Chemical group 0.000 description 11
- LCGTWRLJTMHIQZ-UHFFFAOYSA-N 5H-dibenzo[b,f]azepine Chemical compound C1=CC2=CC=CC=C2NC2=CC=CC=C21 LCGTWRLJTMHIQZ-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000000155 melt Substances 0.000 description 5
- WXGBMVAPOXRLDB-UHFFFAOYSA-N 6-(2-phenylethenyl)cyclohexa-2,4-dien-1-imine Chemical class N=C1C=CC=CC1C=CC1=CC=CC=C1 WXGBMVAPOXRLDB-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001339 alkali metal compounds Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229960003750 ethyl chloride Drugs 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Chemical group 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 150000002736 metal compounds Chemical class 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229960005141 piperazine Drugs 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical group C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- FYFJMRRHHBAMEH-UHFFFAOYSA-N 4-imino-3-(2-phenylethenyl)cyclohexa-1,5-diene-1-carbonyl chloride Chemical compound N=C1C=CC(C(=O)Cl)=CC1C=CC1=CC=CC=C1 FYFJMRRHHBAMEH-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
Definitions
- alkylene represents a 2-6 carbon alkylene chain separating the adjacent nitrogen atoms to which it is attached by at least two carbon atoms
- j R represents a lower alkyl, lower alkanoyloxyalkyl or lower hydroxalkyl radical
- R is the methyl, hydroxyethyl or acetoxyethyl radical and alkylene is the 1.3-propylene radical (trimethylene radical).
- the new compounds are produced by reacting an iminostilbene of the general formula /NY clan-0H2 (III) wherein Y represents a low molecular alkyl or alkanoyl- HO-alkylene-N Riehen, near Basel, Switzerland, as-
- sodium amide, lithium amide, potassium amide, sodium, lithium or potassium are suitable acid binding agents; and the alkali metal compounds are suit able as metal compounds of the iminostilbenes.
- the halides also for example, aryl sulphonic acid esters and alkali metal salts of acid sulphuric acid esters are used as reactive esters of amino alcohols of the general Formula III; in particular can be named: [3-(4-rnethyl-piperazino) -ethyl chloride, fl-(4-isopropyl-piperazino) -ethyl chloride, ,3-(4-allyl-piperazino) -ethyl chloride, fl-(4-ethyl-piperazino)-propyl chloride, 6-(4-isobutyl-piperazino)-propyl chloride, -(4-methyl-piperazino) -propyl chloride, 'y-(
- Iminostilbene and 3.7-dichloro-iminostilbene are the starting compounds of general Formula 11. They are obtained from irninodibenzyl or 3.7-dichloro-iminodibenzyl respectively by converting them into the N-acyl derivatives which canbe easily split, halogenating, for example with bromosuccinimide, splitting oif hydrogen halide and hydrolyzing.
- alkylene-OH (IV) wherein alkylene and X have the meanings given above, in particular an ester of a halogen hydracid or aryl sulphonic acid, with an N-substituted piperazine of the 'general formula:
- Starting materials of the general Formula IV are ob tained for example, by reacting alkali metal compounds of iminostilbenes of the general Formula II with reactive diesters of alkandiols, in particular those with two different acid components such as, for example u-bromofi-chloralkanes, o-bromo-w-chloralkanes, aryl sulphonic acid esters of chloralkanols and bromalkanols as well as alkali metal salts of acid chloralkyl and bromalkyl sulphuric acid esters.
- N-substituted pipera zines of the general Formula V are N-methyl-, N -ethyl-, N-n-propyl-, N-fi-hydroxyethyL, N-y-hydroxypropyh, N- fi-hydroxybutyland N.B-acetoxyethyl-piperazine.
- N-substituted iminostilbenes of the general Formula I can be produced by reacting a piperazinoalkyl-iminostilbene 7 of the general formula -with a reactive ester of and B-bromoethyl acetate.
- As reactive esters of alcohols of the general Formula VII can be named methyl bromide, methyl iodide, ethyl bromide, ethyl iodide, n-butyl bromide, dimethyl sulphate, diethyl sulphate, ,B-chlorethyl acetate
- alkylene oxides can be named ethylene oxide and propylene oxide.
- the new N-substituted iminostilbenes of the general Formula I can also be produced by reacting an iminostilbene of the general Formula II, possibly in the presence of an acid binding agent, or reacting a metal compound of such an irninostilbene, with phosgene, re-
- compounds of the general Formula I in which R is a lower hydroxyalkyl radical can be esterified to form compounds of the same general Formula I in which R is a lower alkanoyloxyalkyl radical.
- the tertiary bases form salts with inorganic or organic acids such as hydrochloric acid, hydrobromic acid, sulphuric acid, phosphoric acid, methane sulphonic acid,
- ethane sulphonic acid ethane disulphonic acid
- acetic acid citric acid, malic acid, succinic acid, maleic acid, fumaric acid, tartaric acid, benzoic acid and phthalic acid.
- Some of these salts are water soluble.
- Example I 9.7 parts of iminostilbene are dissolved in 150 parts by volume of anh. benzene and the base from parts of 1- ('y-chloropropyl) -4-methyl-pipera zine dihydrochloride in 300 parts by volume of benzene is added. A suspen sion of 2.5 parts of sodium amide in toluene is added dropwise at 40-50 while stirring Well. The reaction mixture is stirred for 3 hours at 50 and then boiled under reflux for 16 hours. It is then cooled to room temperature and water is added. The benzene phase is removed and shaken out several times with diluted acetic acid. The combined acetic acid extracts are made al kaline with concentrated caustic soda lye.
- Example 2 13 parts of 3.7-dichloro-iminostilbene are dissolved in 300 parts by volume of anh. benzene and the solution of the base from 14 parts of l-(v-chloro-propyl)-4-methy1- piperazine dihydrochloride in 200 parts by volume of anh. benzene is added. 2.5 parts of sodium amide, sus
- Example 3 19 parts of iminostilbene and 20 parts of 1-chloro-3- bromopropane are dissolved in 800 parts by volume of anh. benzene and 4.4 parts of sodium amide intoluene are added dropwise while stirring strongly, the addition being made within half an hour at 50. On completion of the dropwise addition, the whole is stirred for another 3 hours at 50-60 and then refluxedfor 3 hours. After cooling, water is added to the reaction mixture and the benzene phase is separated, washed with water, dried and concentrated. The oily residue is dissolved in 400 parts by volume of petroleum ether, any undissolved iminostilbene is filtered off and the solvent is evaporated. Oily N-(v-chloropropyl)-iminostilbene remains which, after recrystallisation from anh. ether, melts at 6'7.
- the dihydrochloride prepared with alcoholic hydrochloric acid melts at 228-230 N-[y-(4 hydroxyethyl-piperazine)-propyl]3.7 dichloroiminostilbene and its dihydrochloride can be produced in an analogous manner.
- Example 4 1 part of N-[w(4-hydroxyethyl-piperazino)-propyl]- iminostilbene and 5 partes of acetic acid anhydride are refluxed for 4 hours. The excess acetanhydride is evaporated in the vacuum, the residue is dissolved in cold water, the solution is filtered and the filtrate is made alkaline with sodium carbonate solution. The precipitate is dissolved in either, the ether solution is washed with water, dried over sodium sulphate and the solvent is distilled on. The residue is dissolved in petroleum ether, the solution is filtered and the filtrate is concentrated. N-[y-(4-acetoxyethyl-piperazino) -propyl] -iminostilbene is obtained as a yellow oil.
- N-[' -(4-acetoxyethyl-piperazino) )-propyl]'-3.7-dichloro-iminostilbene and its dihydrochloride are obtained from N-[y-( l-hydroxyethyl piperazinzon -propyl] -3 .7-dichloro-iminostilbene.
- X represents a member selected from the group consisting of hydrogen and chlorine
- 'alkylene represents a 26 carbon alkylene chain separating the adjacent nitrogen atoms to which it is attached by at least two carbon atoms
- R represents a member selected from the group consisting of lower alkyl, lower alkanoyloxyalkyl and lower hydroxyalkyl.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH4591057A CH364263A (de) | 1957-05-09 | 1957-05-09 | Verfahren zur Herstellung von basisch substituierten Azepinen |
CH5833258A CH366542A (de) | 1957-05-09 | 1958-04-15 | Verfahren zur Herstellung von basischen Derivaten von Azepinen |
Publications (1)
Publication Number | Publication Date |
---|---|
US3133068A true US3133068A (en) | 1964-05-12 |
Family
ID=25737647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US832498A Expired - Lifetime US3133068A (en) | 1957-05-09 | 1959-08-10 | 5-substituted dibenz[b, f] azepine compounds |
Country Status (7)
Country | Link |
---|---|
US (1) | US3133068A (en(2012)) |
BE (1) | BE567519A (en(2012)) |
CH (4) | CH364263A (en(2012)) |
DE (1) | DE1133729B (en(2012)) |
FR (1) | FR1226426A (en(2012)) |
GB (1) | GB862297A (en(2012)) |
NL (1) | NL103879C (en(2012)) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947447A (en) * | 1974-05-20 | 1976-03-30 | American Hoechst Corporation | 5H-aminoacetamido-10,11-dihydrodibenz-[b,f]azepines and immediate precursors |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5599929A (en) * | 1994-11-09 | 1997-02-04 | Taro Pharmaceutical Industries Ltd | Method for preparing opipramol |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2541211A (en) * | 1948-10-15 | 1951-02-13 | Searle & Co | Tertiary-aminoalkyl-tetrahydrocarbazoles |
US2676966A (en) * | 1951-04-04 | 1954-04-27 | Searle & Co | Quaternary salts of 9-carbazolealkylamines and 10-acridanalkylamines and methods forpreparing same |
US2676971A (en) * | 1951-04-21 | 1954-04-27 | Searle & Co | Quaternary ammonium derivatives of aminoalkylxanthenes and aminoalkylthiaxanthenes |
US2861987A (en) * | 1955-12-28 | 1958-11-25 | Cilag Ltd | New diphenyl methane- and 1-aza-[2,3:5,6]-dibenzocy cloheptadiene derivatives, theiracid salts and quaternary salts and the production thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL95693C (en(2012)) * | 1955-10-20 |
-
1957
- 1957-05-09 CH CH4591057A patent/CH364263A/de unknown
- 1957-05-09 CH CH359143D patent/CH359143A/de unknown
- 1957-05-09 CH CH360061D patent/CH360061A/de unknown
-
1958
- 1958-04-15 CH CH5833258A patent/CH366542A/de unknown
- 1958-05-07 FR FR765074A patent/FR1226426A/fr not_active Expired
- 1958-05-08 DE DEG30349A patent/DE1133729B/de active Pending
- 1958-05-08 NL NL227620A patent/NL103879C/xx active
- 1958-05-08 BE BE567519D patent/BE567519A/xx unknown
- 1958-05-08 GB GB14737/58A patent/GB862297A/en not_active Expired
-
1959
- 1959-08-10 US US832498A patent/US3133068A/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2541211A (en) * | 1948-10-15 | 1951-02-13 | Searle & Co | Tertiary-aminoalkyl-tetrahydrocarbazoles |
US2676966A (en) * | 1951-04-04 | 1954-04-27 | Searle & Co | Quaternary salts of 9-carbazolealkylamines and 10-acridanalkylamines and methods forpreparing same |
US2676971A (en) * | 1951-04-21 | 1954-04-27 | Searle & Co | Quaternary ammonium derivatives of aminoalkylxanthenes and aminoalkylthiaxanthenes |
US2861987A (en) * | 1955-12-28 | 1958-11-25 | Cilag Ltd | New diphenyl methane- and 1-aza-[2,3:5,6]-dibenzocy cloheptadiene derivatives, theiracid salts and quaternary salts and the production thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947447A (en) * | 1974-05-20 | 1976-03-30 | American Hoechst Corporation | 5H-aminoacetamido-10,11-dihydrodibenz-[b,f]azepines and immediate precursors |
Also Published As
Publication number | Publication date |
---|---|
DE1133729B (de) | 1962-07-26 |
CH364263A (de) | 1962-09-15 |
NL103879C (en(2012)) | 1963-02-15 |
CH366542A (de) | 1963-01-15 |
CH360061A (de) | 1962-02-15 |
GB862297A (en) | 1961-03-08 |
BE567519A (en(2012)) | 1958-11-08 |
CH359143A (de) | 1961-12-31 |
FR1226426A (fr) | 1960-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2921069A (en) | Substituted trifluroromethylpheno-thiazine derivatives | |
US3058979A (en) | New perfluoroalkylphenothiazine derivatives | |
NO155805B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter. | |
NO118710B (en(2012)) | ||
NO164169B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater. | |
US3133068A (en) | 5-substituted dibenz[b, f] azepine compounds | |
US2987517A (en) | Alpha aryl-3-methyl-pentanoic acid-nu-lower alkyl heterocyclic esters | |
US3467650A (en) | 3 - chloro - 5 - (alpha - dimethylaminopropyl)-iminodibenzyl and its acid addition salts | |
US3161637A (en) | 1-(gamma-aroyl-propyl)-4-(nu-arylcarbonyl amino) piperidines and related compounds | |
US3252984A (en) | Esters of xanthenylpiperidinecarboxylic acid and related compounds | |
US2794810A (en) | Aminoalkyl cycloalkylcarbamates | |
US2836595A (en) | Piperazine derivatives and process for | |
US2898336A (en) | Phenthiazine derivatives | |
US2694705A (en) | Nx c c ox a a | |
US2767179A (en) | Quaternary ammonium salts of carboline derivatives | |
US2861987A (en) | New diphenyl methane- and 1-aza-[2,3:5,6]-dibenzocy cloheptadiene derivatives, theiracid salts and quaternary salts and the production thereof | |
US3040031A (en) | N-heterocyclic compounds | |
US2898340A (en) | 2,2-diaryl-omega-(4'-phenyl-1'-piperidino) alkanonitriles | |
US2965639A (en) | New basically substituted azepine | |
US2772289A (en) | Basic esters of n-aralkyl-n-aryl-carbamic acids and the manufacture thereof | |
US2926164A (en) | N-(chlorophenothiazinealkyl)-3 and 4-(hydroxy alkyl)piperidines | |
US3140286A (en) | Nu-(chlorophenyl)-nu-phenyl-nu'-2[(hydroxylower alkyl)-piperidino]-ethyl ureas | |
US3123610A (en) | Alkanoylpiperidinoalkyl | |
US3435028A (en) | Iminodibenzyl derivatives | |
US3010961A (en) | Basically substituted derivatives of 11 hquinoxalino [2.3-b]-p-benzothiazines |